Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
10/17/2007EP0970195B1 Fatty-acid amide hydrolase
10/17/2007CN101056859A Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand
10/17/2007CN101056855A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
10/17/2007CN101056637A Pharmaceutical composition for transdermal administration of perospirone
10/17/2007CN101056630A Vitamin e for facilitating the synchronization of circadian rhythm
10/17/2007CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007CN101054379A Pyrrole substituted pyrimidinone derivative, preparation method and use thereof in medicine
10/17/2007CN101053654A Orally administered medicine in traditional Chinese medicine treating 'hyperhidrosis companied with warm-liking and cold-disgusting'
10/17/2007CN101053628A Orally administered medicine in traditional Chinese medicine treating 'hyperhidrosis companied with burning sensation of five centers'
10/17/2007CN101053557A Noradrenaline bitartrate medicine composition frozen dried powder injection
10/17/2007CN101053429A Refreshment eyesight improving matrimony vine beverage
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100343252C Novel imidazopyridine compounds with therapeutic effect
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/17/2007CN100343250C Indolyl derivatives
10/17/2007CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/17/2007CN100343237C Amide derivative and medicine
10/16/2007USRE39888 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282564 RNA interference pathway genes as tools for targeted genetic interference
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery
10/16/2007US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2336654C Plaster which contains steroids, and a method for the production and use thereof
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2326413C Process for enriching for helicobacter pylori neutrophil activating protein (nap)
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors
10/16/2007CA2131904C Reconstituted cartilage tissue
10/11/2007WO2007114380A1 Agent for external application to the skin
10/11/2007WO2007114338A1 Acid secretion inhibitor
10/11/2007WO2007114325A1 Antibody modification method for purifying bispecific antibody
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114239A1 ANTI-CANCER AGENT COMPRISING DGKα INHIBITOR
10/11/2007WO2007114230A1 Thioredoxin production promoting agent
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007114124A1 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11β-HYDROXYSTEROID DEHYDROGENASE TYPE I
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007071967A3 Substituted phenol derivatives as analgesics
10/11/2007WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238875 Heterocyclic compounds
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238791 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238758 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
10/11/2007US20070238757 Novel treatment
10/11/2007US20070238749 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238729 Dna-pk inhibitors
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070238638 Bak promoter expression system
10/11/2007US20070238171 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2007US20070237770 Novel compositions and methods in cancer
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237751 Human Cord Blood as a Source of Neural Tissue Repair of the Brain and Spinal Cord
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007DE19701619B4 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome
10/11/2007DE102006016365A1 Composition for inhibiting expression of one or more target genes in a eukaryotic cell comprises one or more genetic constructs comprising a target gene and a small interfering RNA tag
10/11/2007CA2647968A1 Agent for promoting the production of thioredoxin
10/11/2007CA2647862A1 Acid secretion inhibitor
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/10/2007EP1842557A1 Drug carrier and drug carrier kit for inhibiting fibrosis
10/10/2007EP1842556A1 Therapeutic agent for attention-deficit hyperactivity disorder
10/10/2007EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007EP1842541A1 Plant components and extracts and uses thereof
10/10/2007EP1842540A1 Sesamin/episesamin compositions
10/10/2007EP1842538A2 Treatment for Raynaud's Phenomenon
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1558252B1 Substituted furo [2,3-b]pyridine derivatives
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 1564